Literature DB >> 27544535

In Vitro Activity of Melaleuca alternifolia (Tea Tree) in Its Free Oil and Nanoemulsion Formulations Against Pythium insidiosum.

Júlia de Souza Silveira Valente1, Anelise de Oliveira da Silva Fonseca1, Carolina Litchina Brasil1, Lauren Sagave2, Fernanda Cramer Flores3, Cristiane de Bona da Silva3, Luís Antônio Sangioni2, Luciana Pötter2, Janio Morais Santurio3, Sônia de Avila Botton2, Daniela Isabel Brayer Pereira4.   

Abstract

Pythium insidiosum is an important aquatic oomycete which can cause pythiosis in both animals and humans. This microorganism shows low susceptibility to antifungal drugs available. This study analyzed the in vitro antimicrobial activity of Melaleuca alternifolia in its free oil (FO) and nanoemulsion (NE) formulations against Brazilian P. insidiosum isolates. The antimicrobial activity evaluation was performed by the broth microdilution method according to CSLI M38-A2 document adapted to phytopharmaceuticals. Twenty-six P. insidiosum isolates were evaluated, and the minimum inhibitory concentration was determined at 100 % growth inhibition. Melaleuca alternifolia essential oil or FO was obtained commercially. The NE containing 1 % M. alternifolia essential oil was prepared by the spontaneous emulsification method. All P. insidiosum isolates evaluated showed minimum inhibitory concentrations (MIC) ranging from 531.5 to 2125 μg/mL for the FO formulation; MIC50 and MIC90 showed values between 1062.5 and 2125 μg/mL, respectively. When the NE formulation was evaluated, MIC values ranged from 132.7 to 2125 μg/mL and both MIC50 and MIC90 corresponded to 1062.5 μg/mL. FO and NE formulations of M. alternifolia showed antimicrobial activity against P. insidiosum. This study demonstrated that M. alternifolia oil can be an additional therapy in pythiosis treatment; however, further studies are needed to evaluate the applicability of the plant essential oils in the treatment of clinical pythiosis.

Entities:  

Keywords:  Medicinal plants; Nanostructured systems; Oomycete; Pythiosis

Mesh:

Substances:

Year:  2016        PMID: 27544535     DOI: 10.1007/s11046-016-0051-2

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  19 in total

1.  Nano-emulsion formulation using spontaneous emulsification: solvent, oil and surfactant optimisation.

Authors:  K Bouchemal; S Briançon; E Perrier; H Fessi
Journal:  Int J Pharm       Date:  2004-08-06       Impact factor: 5.875

2.  Coumarinoids from the fruits of Micromelum falcatum.

Authors:  Jittra Suthiwong; Uraiwan Sriphana; Yordhathai Thongsri; Pawantree Promsuwan; Chularut Prariyachatigul; Chavi Yenjai
Journal:  Fitoterapia       Date:  2014-02-19       Impact factor: 2.882

3.  In vitro activity of carvacrol and thymol combined with antifungals or antibacterials against Pythium insidiosum.

Authors:  F P K Jesus; L Ferreiro; K S Bizzi; É S Loreto; M B Pilotto; A Ludwig; S H Alves; R A Zanette; J M Santurio
Journal:  J Mycol Med       Date:  2014-11-13       Impact factor: 2.391

4.  Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy.

Authors:  Christine F Carson; Brian J Mee; Thomas V Riley
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

Review 5.  Pythium insidiosum: an overview.

Authors:  Wim Gaastra; Len J A Lipman; Arthur W A M De Cock; Tim K Exel; Raymond B G Pegge; Josje Scheurwater; Raquel Vilela; Leonel Mendoza
Journal:  Vet Microbiol       Date:  2010-07-24       Impact factor: 3.293

6.  In vitro activity of Melaleuca alternifolia (tea tree) oil against dermatophytes and other filamentous fungi.

Authors:  K A Hammer; C F Carson; T V Riley
Journal:  J Antimicrob Chemother       Date:  2002-08       Impact factor: 5.790

7.  In vitro susceptibility of zoospores and hyphae of Pythium insidiosum to antifungals.

Authors:  A O S Fonseca; D I B Pereira; F S Maia Filho; L G Osório; B P Maroneze; J S S Valente; L Pötter; M C A Meireles
Journal:  J Antimicrob Chemother       Date:  2014-02-11       Impact factor: 5.790

8.  Trypanocidal action of tea tree oil (Melaleuca alternifolia) against Trypanosoma evansi in vitro and in vivo used mice as experimental model.

Authors:  Matheus D Baldissera; Aleksandro S Da Silva; Camila B Oliveira; Roberto C V Santos; Rodrigo A Vaucher; Renata P Raffin; Patrícia Gomes; Maria G C Dambros; Luiz C Miletti; Aline A Boligon; Margareth L Athayde; Silvia G Monteiro
Journal:  Exp Parasitol       Date:  2014-03-19       Impact factor: 2.011

9.  Antifungal activity of nanocapsule suspensions containing tea tree oil on the growth of Trichophyton rubrum.

Authors:  F C Flores; J A de Lima; R F Ribeiro; S H Alves; C M B Rolim; R C R Beck; Cristiane Bona da Silva
Journal:  Mycopathologia       Date:  2013-02-08       Impact factor: 2.574

10.  Antimicrobial activities of the essential oils of various plants against tomato late blight disease agent Phytophthora infestans.

Authors:  E Mine Soylu; Soner Soylu; Sener Kurt
Journal:  Mycopathologia       Date:  2006-02       Impact factor: 2.574

View more
  3 in total

1.  Melaleuca alternifolia formulations in the treatment of experimental pythiosis.

Authors:  Júlia de Souza Silveira; Carolina Litchina Brasil; Caroline Quintana Braga; Ândrios da Silva Moreira; Helen Cabaldi Franz; Rosimeri Zamboni; Eliza Simone Sallis; Ana Paula Albano; Cristina Gomes Zambrano; Lara Colles Araujo; Cristiane de Bona da Silva; Luciana Pötter; Sônia de Avila Botton; Daniela Isabel Brayer Pereira
Journal:  Braz J Microbiol       Date:  2022-03-03       Impact factor: 2.214

Review 2.  Review of methods and antimicrobial agents for susceptibility testing against Pythium insidiosum.

Authors:  Hanna Yolanda; Theerapong Krajaejun
Journal:  Heliyon       Date:  2020-04-12

Review 3.  Use of Essential Oils in Veterinary Medicine to Combat Bacterial and Fungal Infections.

Authors:  Valentina Virginia Ebani; Francesca Mancianti
Journal:  Vet Sci       Date:  2020-11-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.